| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
42,630 |
34,548 |
$2.17M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
21,263 |
17,038 |
$1.54M |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
57,432 |
43,054 |
$1.51M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
33,229 |
26,684 |
$1.05M |
| 99215 |
Prolong outpt/office vis |
14,690 |
10,623 |
$903K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
17,824 |
14,896 |
$783K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
7,273 |
4,719 |
$384K |
| 99205 |
Prolong outpt/office vis |
3,757 |
3,182 |
$360K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15,870 |
5,721 |
$277K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
31,903 |
12,926 |
$270K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
5,199 |
4,646 |
$189K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,987 |
3,282 |
$160K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
7,451 |
6,169 |
$143K |
| 99050 |
|
18,427 |
13,283 |
$134K |
| 81025 |
|
29,447 |
21,658 |
$124K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,867 |
9,021 |
$103K |
| 99051 |
|
8,696 |
7,038 |
$85K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
461 |
394 |
$47K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
24,471 |
16,794 |
$46K |
| 0240U |
|
455 |
375 |
$42K |
| 86328 |
|
1,787 |
902 |
$38K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
735 |
510 |
$31K |
| 87634 |
|
801 |
442 |
$26K |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
3,181 |
2,325 |
$19K |
| 81003 |
|
15,820 |
11,475 |
$18K |
| 87807 |
|
1,150 |
955 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,075 |
759 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
11,927 |
9,262 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
716 |
534 |
$6K |
| 92551 |
|
826 |
784 |
$6K |
| 0011A |
|
402 |
208 |
$5K |
| 0012A |
|
249 |
144 |
$4K |
| 99173 |
|
2,896 |
2,739 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
148 |
114 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
130 |
84 |
$2K |
| 90832 |
Psychotherapy, 30 minutes with patient |
56 |
37 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,744 |
1,382 |
$2K |
| 0001A |
|
75 |
60 |
$2K |
| 90656 |
|
183 |
159 |
$1K |
| 92587 |
|
75 |
60 |
$1K |
| G9919 |
Screening performed and positive and provision of recommendations |
351 |
263 |
$780.00 |
| 90674 |
|
79 |
46 |
$680.00 |
| 82962 |
|
358 |
233 |
$543.24 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
23 |
14 |
$537.46 |
| Q3014 |
Telehealth originating site facility fee |
233 |
154 |
$440.00 |
| 90756 |
|
36 |
24 |
$413.32 |
| 0002A |
|
31 |
13 |
$334.56 |
| 36415 |
Collection of venous blood by venipuncture |
201 |
172 |
$317.67 |
| 72040 |
|
13 |
13 |
$256.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,048 |
5,892 |
$245.27 |
| 72100 |
|
12 |
12 |
$244.90 |
| 82948 |
|
199 |
131 |
$237.00 |
| 90714 |
|
23 |
14 |
$213.48 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
87 |
58 |
$84.72 |
| 91301 |
|
321 |
254 |
$74.16 |
| 76140 |
|
1,630 |
1,105 |
$45.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16 |
14 |
$11.70 |
| 91300 |
|
88 |
72 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
1,116 |
623 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
17 |
12 |
$0.00 |
| 99000 |
|
369 |
223 |
$0.00 |